News | January 04, 2023
Themis Medicare launches Lenzetto for treatment of menopausal symptoms
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
BDRs journey for the treatment of Prostate Cancer started with Abiratarone Acetate, then Leuprolide Acetate followed by Enzalutamide and, then Degarelix and Triptorelin.
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
The company is one of the most profitable companies manufacturing speciality chemicals in India
Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals
The cash and debt free consideration value is €370 million.
MindRank expects to initiate a Phase I safety study in the first quarter of 2023.
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
Subscribe To Our Newsletter & Stay Updated
